ES356142A1 - Un procedimiento para producir un preparado antibacteriano. - Google Patents
Un procedimiento para producir un preparado antibacteriano.Info
- Publication number
- ES356142A1 ES356142A1 ES356142A ES356142A ES356142A1 ES 356142 A1 ES356142 A1 ES 356142A1 ES 356142 A ES356142 A ES 356142A ES 356142 A ES356142 A ES 356142A ES 356142 A1 ES356142 A1 ES 356142A1
- Authority
- ES
- Spain
- Prior art keywords
- silver
- carrier
- therapeutic agents
- containing therapeutic
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229910052709 silver Inorganic materials 0.000 title abstract 11
- 239000004332 silver Substances 0.000 title abstract 11
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title abstract 10
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- RRDRHWJDBOGQHN-JWCTVYNTSA-N [2-[(2s,5r,8s,11s,14r,17s,22s)-17-[(1r)-1-hydroxyethyl]-22-[[(2s)-2-[[(2s,3r)-3-hydroxy-2-[[(2s)-2-[6-methyloctanoyl(sulfomethyl)amino]-4-(sulfomethylamino)butanoyl]amino]butyl]amino]-4-(sulfomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15 Chemical compound CCC(C)CCCCC(=O)N(CS(O)(=O)=O)[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCNCS(O)(=O)=O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CCNCS(O)(=O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(O)(=O)=O)NC1=O RRDRHWJDBOGQHN-JWCTVYNTSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 abstract 1
- 229960000603 cefalotin Drugs 0.000 abstract 1
- 229940108538 colistimethate Drugs 0.000 abstract 1
- 108700028201 colistinmethanesulfonic acid Proteins 0.000 abstract 1
- 239000008311 hydrophilic ointment Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- NBYLLBXLDOPANK-UHFFFAOYSA-M silver 2-carboxyphenolate hydrate Chemical compound C1=CC=C(C(=C1)C(=O)O)[O-].O.[Ag+] NBYLLBXLDOPANK-UHFFFAOYSA-M 0.000 abstract 1
- -1 silver tetracycline Chemical class 0.000 abstract 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 abstract 1
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960002597 sulfamerazine Drugs 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002211 sulfapyridine Drugs 0.000 abstract 1
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 abstract 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001544 sulfathiazole Drugs 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65383067A | 1967-07-17 | 1967-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES356142A1 true ES356142A1 (es) | 1970-02-16 |
Family
ID=24622450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES356142A Expired ES356142A1 (es) | 1967-07-17 | 1968-07-13 | Un procedimiento para producir un preparado antibacteriano. |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE718183A (enrdf_load_stackoverflow) |
| DE (1) | DE1792053B1 (enrdf_load_stackoverflow) |
| ES (1) | ES356142A1 (enrdf_load_stackoverflow) |
| FR (2) | FR1586125A (enrdf_load_stackoverflow) |
| GB (2) | GB1240545A (enrdf_load_stackoverflow) |
| IE (1) | IE32197B1 (enrdf_load_stackoverflow) |
| NL (1) | NL6809794A (enrdf_load_stackoverflow) |
| PH (1) | PH10639A (enrdf_load_stackoverflow) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049802A (en) | 1975-03-19 | 1977-09-20 | Research Corporation | Zinc sulfadiazine and its use in the treatment of burns |
| DE2804931A1 (de) * | 1978-02-06 | 1979-08-16 | Fresenius Chem Pharm Ind | Metallsulfadiazine in feinteiliger form |
| US4384117A (en) * | 1980-03-18 | 1983-05-17 | The United States Of America As Represented By The Secretary Of The Army | Silver metachloridine |
| US4933330A (en) * | 1987-04-01 | 1990-06-12 | Dak-Laboratoriet | Benzoic acid derivatives and use thereof |
| CA2024220A1 (en) * | 1990-08-29 | 1992-03-01 | Don Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| IT1243435B (it) * | 1990-10-05 | 1994-06-10 | Altergon Sa | Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti |
| US7074788B2 (en) | 2001-11-22 | 2006-07-11 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| EP1631558A1 (en) * | 2003-05-21 | 2006-03-08 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| US7173030B2 (en) | 2003-05-21 | 2007-02-06 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| SE0301882D0 (sv) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use I |
| SE0301886D0 (sv) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use V |
| SE0301884D0 (sv) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use III |
| SE0301888D0 (sv) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use VII |
| SE0301885D0 (sv) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use IV |
| WO2004113310A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| BRPI1104620B1 (pt) * | 2011-09-09 | 2020-04-07 | Lucia Teixeira De Carvalho | composição farmacêutica para tratamento de queimaduras e lesões da pele e seu processo de preparação |
-
1968
- 1968-07-05 PH PH9358A patent/PH10639A/en unknown
- 1968-07-10 NL NL6809794A patent/NL6809794A/xx unknown
- 1968-07-13 ES ES356142A patent/ES356142A1/es not_active Expired
- 1968-07-15 IE IE83968A patent/IE32197B1/xx unknown
- 1968-07-16 GB GB33831/68A patent/GB1240545A/en not_active Expired
- 1968-07-16 GB GB4945970A patent/GB1240546A/en not_active Expired
- 1968-07-16 FR FR1586125D patent/FR1586125A/fr not_active Expired
- 1968-07-17 BE BE718183D patent/BE718183A/xx not_active IP Right Cessation
- 1968-07-17 DE DE19681792053 patent/DE1792053B1/de active Pending
- 1968-10-11 FR FR169591A patent/FR8146M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PH10639A (en) | 1977-07-22 |
| FR1586125A (enrdf_load_stackoverflow) | 1970-02-13 |
| FR8146M (enrdf_load_stackoverflow) | 1970-08-17 |
| DE1792053B1 (de) | 1971-07-29 |
| IE32197L (en) | 1969-01-17 |
| GB1240545A (en) | 1971-07-28 |
| BE718183A (enrdf_load_stackoverflow) | 1969-01-17 |
| NL6809794A (enrdf_load_stackoverflow) | 1969-01-21 |
| IE32197B1 (en) | 1973-05-16 |
| GB1240546A (en) | 1971-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES356142A1 (es) | Un procedimiento para producir un preparado antibacteriano. | |
| CA970908A (en) | Stable aqueous dispersions of optical brightening agents | |
| ES414888A1 (es) | Metodo de preparar compuestos triciclicos de azufre antia- lergicos. | |
| DK120731B (da) | Phytologisk aktivt middel. | |
| AU452550B2 (en) | The use of diphenylsulfones inthe treatment of mareks disease | |
| ES368399A1 (es) | Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilamino propanos sustituidos. | |
| CA953057A (en) | Treatment of optical brightening agents | |
| AU452927B2 (en) | Production of anhydrous chloroferrate complexes from ferric chloride inan aqueous system | |
| CA767590A (en) | Process for treatment of sodium chloride | |
| FR2312M (fr) | Nouveau sel potassique de toxicité réduite pour le traitement des hypokaliémies : ascorbate de potassium. | |
| CA762433A (en) | Treatment of titanium surfaces | |
| GB1107106A (en) | Novel triamines | |
| FR2510M (fr) | Nouveau médicament utilisable pour le traitement des infections staphylococciques et analogues. | |
| CA754991A (en) | Potassium chloride treatment | |
| ES276824A1 (es) | Procedimiento para la rectificación de baños salinos fundidos | |
| GB1194912A (en) | Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin | |
| CA649784A (en) | Alkali metal salt of carboxymethylcellulose | |
| CA388849A (en) | Desiccated biologically active substance preservation | |
| FR2168924A2 (en) | Hetacephalexin compsns - for human and veterinary antibacterial therapy, and as foodstuff additive | |
| AU433400B2 (en) | Treatment of chlorine | |
| CA859747A (en) | Metal salt complexes of imidazolylphosphonothioates | |
| CA846228A (en) | Deodorizing treatment of aqueous solutions | |
| AU424350B2 (en) | Treatment of steel | |
| AU5962469A (en) | Treatment of chlorine | |
| AU167175B2 (en) | Treatment of titanium metal sponge |